Microbiology Technology, Equipment and Consumables Market Report 2026

The microbiology technology, equipment and consumables market size has grown rapidly in recent years. It will grow from $7.73 billion in 2025 to $8.63 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, expansion of clinical diagnostic laboratories, growth of food safety testing requirements, rising pharmaceutical quality testing needs, availability of standardized consumables.

The microbiology technology, equipment and consumables market size is expected to see rapid growth in the next few years. It will grow to $13.24 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing investments in molecular diagnostics, rising demand for automation in labs, expansion of environmental monitoring programs, growing focus on antimicrobial resistance testing, increasing adoption of digital microbiology platforms. Major trends in the forecast period include increasing adoption of automated microbiology systems, rising demand for rapid diagnostic technologies, growing use of molecular microbiology techniques, expansion of digital laboratory workflows, enhanced focus on high-throughput testing.

The rising hospital-acquired infection rates are expected to drive the growth of the microbiology technology, equipment, and consumables market in the coming years. Hospital-acquired infection rates indicate the proportion of patients who develop infections during their stay in a healthcare facility that were not present upon admission. The increase in hospital-acquired infection rates is attributed to invasive devices and procedures that heighten patient exposure to pathogens and infection risk. Microbiology technology, equipment, and consumables assist in reducing hospital-acquired infection rates by enabling the rapid detection, monitoring, and control of infectious pathogens, thereby limiting their spread within healthcare settings. For example, in June 2025, the Australian Institute of Health and Welfare, an Australia-based government department, reported that out of approximately 12.6 million hospital admissions, around 150,000 involved at least one hospital-acquired complication in 2023-24. The incidence rate of these complications was 1.9 per 100 admissions in public hospitals and 0.8 per 100 admissions in private hospitals. Consequently, the increasing hospital-acquired infection rates are fueling the growth of the microbiology technology, equipment, and consumables market.

Major companies operating in the microbiology technology, equipment, and consumables market are concentrating on creating advanced solutions, such as custom and flexible robotic track configurations, to provide scalable total lab automation solutions that enhance workflow efficiency, shorten turnaround times, and improve diagnostic accuracy in clinical laboratories. Custom and flexible robotic track configuration refers to a modular automation system that can be adapted to a lab’s workflow and physical layout, linking multiple instruments for scalable, end-to-end microbiology processes. For example, in January 2023, Becton, Dickinson and Company, a US-based medical device manufacturer, launched its third-generation BD Kiestra Total Lab Automation System for microbiology laboratories. The system improves testing quality and consistency while decreasing turnaround times, enabling labs to manage growing sample volumes effectively. By automating both routine and complex workflows, it addresses workforce shortages and enhances operational efficiency. Overall, BD’s TLA system provides a cost-effective solution that increases productivity and accuracy in modern clinical microbiology diagnostics.

In January 2023, Haier Biomedical Co. Ltd., a China-based life science company, acquired Suzhou Kangsheng Biotechnology Co. Ltd. for an undisclosed amount. Through this acquisition, Haier Biomedical intends to leverage Suzhou Kangsheng’s expertise in laboratory consumables to enhance its smart laboratory solutions and broaden applications in microbiology, cell culture, and related life science areas. Suzhou Kangsheng Biotechnology Co. Ltd. is a China-based company focusing on microbiology technology, equipment, and consumables.

Major companies operating in the microbiology technology, equipment and consumables market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, 3M Company, MERCK KGaA, Danaher Corporation, Becton, Dickinson and Company, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux Inc., Sartorius AG, Shimadzu Corporation, Sysmex Corporation, Greiner Bio-One International GmbH, Promega Corporation, Oxford Nanopore Technologies Plc, Hardy Diagnostics Co., Copan Diagnostics Inc., Zymo Research Corporation, HiMedia Laboratories Private Limited, Kuhner AG.

North America was the largest region in the microbiology technology, equipment, and consumables market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbiology technology, equipment and consumables market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbiology technology, equipment and consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Higher tariffs are impacting the microbiology technology, equipment, and consumables market by increasing costs of imported instruments, reagents, culture media, sensors, and precision components. Hospitals, diagnostic laboratories, and pharmaceutical companies in North America and Europe are most affected due to heavy reliance on imported laboratory supplies, while Asia-Pacific faces higher costs for exported instruments. These tariffs are raising procurement costs and pressuring laboratory budgets. At the same time, they are supporting domestic manufacturing, local reagent production, and regional supply chain diversification.

The microbiology technology, equipment and consumables market research report is one of a series of new reports that provides microbiology technology, equipment and consumables market statistics, including microbiology technology, equipment and consumables industry global market size, regional shares, competitors with a microbiology technology, equipment and consumables market share, detailed microbiology technology, equipment and consumables market segments, market trends and opportunities, and any further data you may need to thrive in the microbiology technology, equipment and consumables industry. This microbiology technology, equipment and consumables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Microbiology technology, equipment, and consumables include the specialized instruments, tools, and materials employed to study and comprehend microorganisms such as bacteria, fungi, viruses, and protozoa. This area involves the use of advanced laboratory systems and essential supplies that enable the detection, cultivation, and analysis of microbial organisms with accuracy and consistency.

The main product types of microbiology technology, equipment, and consumables include instruments, consumables, and services. Instruments refer to laboratory devices and equipment designed to perform microbiological analyses and experiments with precision and efficiency. They are used for various test types, such as bacterial tests, viral tests, fungal tests, and parasitic tests, and employ different technologies, including conventional microbiology, molecular microbiology, immunology-based methods, and automated and digital systems. The application areas include clinical diagnostics, food and beverage testing, pharmaceuticals and biotechnology, environmental testing, and agricultural and industrial applications, while key end-users include hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, food and beverage companies, academic and research institutes, and environmental and agricultural testing laboratories.

The microbiology technology, equipment, and consumables market consists of revenues earned by entities by providing services such as laboratory testing services, microbiological analysis services, equipment calibration and maintenance, and research and development support. The market value includes the value of related goods sold by the service provider or included within the service offering. The microbiology technology, equipment, and consumables market also includes sales of pipettes, centrifuges, biosafety cabinets, laboratory refrigerators, test tubes, flasks, reagents, lab consumables, and microbial identification kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.